LENSAR ($LNSR) and Alcon End Merger Agreement

NewsDesk - March 16, 2026 5:05 pm

LENSAR, Inc. (NASDAQ: LNSR) announced that it has reached an agreement with Alcon Research, LLC to terminate their merger agreement. LENSAR and Alcon agreed that...

CATALYST News

Outlook Therapeutics ($OTLK) Secures FDA Approval for LYTENAVA™

NewsDesk - July 24, 2026 3:10 pm

Charter Communications ($CHTR) Beats Q2 EPS Estimates; Revenue Decline Driven by Lower Video Revenue

NewsDesk - July 24, 2026 8:21 am

SLB ($SLB) Q2 performance beats expectations; EBITDA and cash flow robust

Staff Writer - July 24, 2026 8:13 am

Sensient Technologies ($SXT) Beats Q2 EPS and Revenue Estimates; Projects Strong FY26 EPS

NewsDesk - July 24, 2026 8:02 am

American Express ($AXP) Beats EPS Estimates; Revenue Misses Amid Strong YoY Growth

Catalyst Desk - July 24, 2026 8:00 am

American Express ($AXP) Beats EPS Estimates; Revenue Misses Amid Strong YoY Growth

Catalyst Desk - July 24, 2026 8:00 am

FDA Approves MannKind’s ($MNKD) Furoscix ReadyFlow for Heart Failure and CKD

NewsDesk - July 24, 2026 7:25 am

Inhibikase ($IKT) Receives FDA Orphan Drug Designation for IKT-001

Catalyst Desk - July 23, 2026 8:23 am

Tesla ($TSLA) Q2 Earnings Miss Expectations; Revenue Surges YoY

Staff Writer - July 22, 2026 5:36 pm

IBM ($IBM) Exceeds Q2 EPS and Revenue Estimates; Software Revenue Up

NewsDesk - July 22, 2026 5:13 pm

Ferguson ($FERG) Strengthens Market Position with FWI Holdings Acquisition

XWELL ($XWEL) Announces Strategic Restructuring with $13M Divestiture

Axos Financial’s ($AX) Subsidiary Expands AI Capabilities with Arc Technologies Acquisition

LENSAR ($LNSR) and Alcon End Merger Agreement

CATALYST News

Outlook Therapeutics ($OTLK) Secures FDA Approval for LYTENAVA™

Charter Communications ($CHTR) Beats Q2 EPS Estimates; Revenue Decline Driven by Lower Video Revenue

SLB ($SLB) Q2 performance beats expectations; EBITDA and cash flow robust

Sensient Technologies ($SXT) Beats Q2 EPS and Revenue Estimates; Projects Strong FY26 EPS

American Express ($AXP) Beats EPS Estimates; Revenue Misses Amid Strong YoY Growth

American Express ($AXP) Beats EPS Estimates; Revenue Misses Amid Strong YoY Growth

FDA Approves MannKind’s ($MNKD) Furoscix ReadyFlow for Heart Failure and CKD

Inhibikase ($IKT) Receives FDA Orphan Drug Designation for IKT-001

Tesla ($TSLA) Q2 Earnings Miss Expectations; Revenue Surges YoY

IBM ($IBM) Exceeds Q2 EPS and Revenue Estimates; Software Revenue Up